| A US population health survey on the impact of COVID-19 using the EQ-5D-5L JW Hay, CL Gong, X Jiao, NK Zawadzki, RS Zawadzki, AS Pickard, F Xie, ... Journal of general internal medicine 36, 1292-1301, 2021 | 70 | 2021 |
| Medicaid Expansion Increased Preconception Health Counseling, Folic Acid Intake, And Postpartum Contraception: Study examines the impact of ACA Medicaid expansion on health … R Myerson, S Crawford, LR Wherry Health Affairs 39 (11), 1883-1890, 2020 | 65 | 2020 |
| A cost-utility analysis of remote pulse-oximetry monitoring of patients with COVID-19 WV Padula, MA Miano, MA Kelley, SA Crawford, BH Choy, RM Hughes, ... Value in Health 25 (6), 890-896, 2022 | 21 | 2022 |
| Coverage for adults with chronic disease under the first 5 years of the Affordable Care Act R Myerson, S Crawford Medical care 58 (10), 861-866, 2020 | 7 | 2020 |
| Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care SA Crawford, CL Gong, L Yieh, LM Randolph, JW Hay Genetics in Medicine 23 (10), 1854-1863, 2021 | 5 | 2021 |
| PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients S Crawford, M Kelley, B Choy, MA Miano, R Grosso, PJ Pronovost, ... Value in Health 24, S109, 2021 | 1 | 2021 |
| PCN324 patient reported outcomes among KTE-X19 CAR T treated patients with relapsed/refractory mantle cell lymphoma (R/R MCL) MJ Kersten, J Munoz, N Milpied, G Maglinte, S Crawford, C Solem, ... Value in Health 23, S479, 2020 | 1 | 2020 |
| Estimating the value of repositioning timing to streamline pressure injury prevention efforts in nursing homes: A cost‐effectiveness analysis of the ‘TEAM‐UP’clinical trial WV Padula, SA Crawford, SM Kennerly, TL Yap International Wound Journal 21 (3), e14452, 2024 | | 2024 |
| Real-World Outcomes Following Dose Modifications of First-Line Ibrutinib in Patients with Waldenström Macroglobulinemia SR Sarosiek, GR von Keudell, J Paludo, M Salkar, B Agatep, A Franco, ... Blood 142, 3780, 2023 | | 2023 |
| IBCL-387 Patient Characteristics and Treatment Patterns of US Medicare Fee-For-Service Beneficiaries With Waldenström Macroglobulinemia S Sarosiek, M Salkar, B Agatep, A Franco, M Pacia, S Crawford Clinical Lymphoma Myeloma and Leukemia 23, S452, 2023 | | 2023 |
| POSTER: IBCL-387 Patient Characteristics and Treatment Patterns of US Medicare Fee-For-Service Beneficiaries With Waldenström Macroglobulinemia S Sarosiek, M Salkar, B Agatep, A Franco, M Pacia, S Crawford Clinical Lymphoma Myeloma and Leukemia 23, S209, 2023 | | 2023 |
| SA34 Real-World Treatment Outcomes Among Relapsed/Refractory Patients with Mantle Cell Lymphoma Treated with Ibrutinib or Acalabrutinib S Crawford, MH Lafeuille, B Emond, D Harb, R Voladarsky, N Chen, ... Value in Health 26 (6), S403, 2023 | | 2023 |
| Association of pharmacist interventions with adherence upon targeted anticancer oral therapy initiation. R Mcshinsky, R Volodarsky, O Ryan, C Li, KM Rasmussen, V Patil, ... Journal of Clinical Oncology 41 (16_suppl), 7576-7576, 2023 | | 2023 |
| Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation M Fradley, MH Lafeuille, B Emond, S Crawford, N Chen, R Volodarsky, ... Blood 140 (Supplement 1), 10983-10984, 2022 | | 2022 |
| Upper Gastrointestinal (GI) Morbidity and Gastric Acid--Reducing Agent (GARA) Use Among Oncolytic-Treated Patients with Non-Hodgkin Lymphomas: Nursing Perspective Insights. M Register, K Terhune, R Volodarsky, S Crawford, S Karve, O Ryan Journal of Oncology Navigation & Survivorship 13 (11), 2022 | | 2022 |
| Upper Gastrointestinal (GI) Morbidity, Peptic Ulcer Risk, and Proton Pump Inhibitor (PPI)/H2 Blocker (H2B) Use in Patients Treated with Bruton's Tyrosine Kinase Inhibitors … S Huntington, R Volodarsky, S Crawford, K Osei-Bonsu, D Mercer, H Sun, ... AMERICAN JOURNAL OF HEMATOLOGY 97, S38-S39, 2022 | | 2022 |
| The Impact of Patient Support Program Participation on Treatment Compliance for Patients Initiating Ibrutinib S Crawford, N Cheng, N Chen, B Srivastava, J Nielsen, S Karve AMERICAN JOURNAL OF HEMATOLOGY 97, S33-S34, 2022 | | 2022 |
| Evaluating Treatment Options for Metastatic, Castration-Resistant Prostate Cancer: A Comprehensive Value Assessment S Crawford University of Southern California, 2022 | | 2022 |
| Changes in Access to Care, Prescription Drug Use and Affordability for People with Diabetes Associated with Medicaid Eligibility Expansions S Crawford, J Romley, R Myerson 10th Annual Conference of the American Society of Health Economists, 2021 | | 2021 |
| EVALUATING REPOSITIONING FREQUENCY IN THE PREVENTION OF PRESSURE INJURIES: AN ECONOMIC ANALYSIS OF THE" TEAM-UP" CLINICAL TRIAL S Crawford, W Padula, S Kennerly, T Yap MEDICAL DECISION MAKING 41 (4), E24-E25, 2021 | | 2021 |
Joel HayProfessor of Health Economics, University of Southern CaliforniaVerified email at usc.edu
